Table 3.
Patient outcomes.
| Variable |
Median (range) or N (%) |
|---|---|
| Reason for discontinuation (n=12) | |
| Disease progression | 9 (75%) |
| Non-compliance | 1 (8.3%) |
| Toxicity | 2 (17%) |
| Best response (n=11) | |
| Stable disease (SD) | 9 (82%) |
| SD ≥90 days | 5 (45%) |
| Progressive disease | 2 (18%) |
| Duration of stable disease (n=9) | 119 (56–429) |